Cancidas and jaundice Patient Reports February 10, 2010

Cancidas Side Effects Report #5403344-X
Cancidas side effect was reported by a Physician from MEXICO on July 30, 2007. Male patient, 60 years of age, weighting 176.4 lb, was diagnosed with respiratory moniliasis, urinary tract infection fungal, renal failure, prophylaxis against gastrointestinal ulcer, pneumonia , analgesia, abdominal pain  and was treated with Cancidas. After drug was administered, patient experienced the following side effects: jaundice . Cancidas dosage: unknown. During the same period patient was treated with FUROSEMIDE, OMEPRAZOLE, CEFTRIAXONE, AMIKACIN, CLONIXIN LYSINE, BUTILHIOSCINA, NIMESULIDE. Patient recovered.

Cancidas Side Effects Report #5453195-5
Cancidas side effect was reported by a Physician from MEXICO on Sept 05, 2007. Male patient, 60 years of age, weighting 176.4 lb, was diagnosed with respiratory moniliasis, urinary tract infection fungal, renal failure, prophylaxis against gastrointestinal ulcer, pneumonia , analgesia, abdominal pain  and was treated with Cancidas. After drug was administered, patient experienced the following side effects: jaundice . Cancidas dosage: unknown. During the same period patient was treated with FUROSEMIDE, OMEPRAZOLE, CEFTRIAXONE, AMIKACIN, CLONIXIN LYSINE, SCOPOLAMINE, NIMESULIDE. Patient recovered.

Cancidas Side Effects Report #5682970-7
Cancidas side effect was reported by a Health Professional from FRANCE on Mar 20, 2008. Male patient, 48 years of age, was diagnosed with mucormycosis, hiv infection  and was treated with Cancidas. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, jaundice . Cancidas dosage: unknown. During the same period patient was treated with POSACONAZOLE, DARUNAVIR, ETRAVIRINE, RITONAVIR, ISENTRESS. Patient recovered.

Cancidas Side Effects Report #5690696-9
Cancidas side effect was reported by a Health Professional from FRANCE on Mar 20, 2008. Male patient, 48 years of age, was diagnosed with mucormycosis, hiv infection  and was treated with Cancidas. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, jaundice . Cancidas dosage: unknown. During the same period patient was treated with POSACONAZOLE, DARUNAVIR, ETRAVIRINE, RITONAVIR, ISENTRESS. Patient was hospitalized. Patient recovered.


Cancidas Side Effects Report #5449483-9
Cancidas side effect was reported by a Consumer or non-health professional from SPAIN on Aug 30, 2007. Female patient, 50 years of age, was diagnosed with lower respiratory tract infection fungal, aplastic anaemia and was treated with Cancidas. After drug was administered, patient experienced the following side effects: cytomegalovirus antibody positive, herpes simplex serology positive, jaundice , parvovirus b19 serology positive, respiratory failure. Cancidas dosage: 70 MG/DAILY. During the same period patient was treated with CYCLOSPORINE, SULFAMETHOXAZOLE TRIMETHOPRIM, MYOLASTAN, NAPROXEN. Patient was hospitalized. Patient died.

Cancidas Side Effects Report #5468674-4
Cancidas side effect was reported by a Consumer or non-health professional from SPAIN on Sept 14, 2007. Female patient, 50 years of age, was diagnosed with lower respiratory tract infection fungal, aplastic anaemia and was treated with Cancidas. After drug was administered, patient experienced the following side effects: bilirubin conjugated increased, jaundice , respiratory failure. Cancidas dosage: 70 MG/DAILY IV. During the same period patient was treated with CYCLOSPORINE, SULFAMETHOXAZOLE TRIMETHOPRIM, MYOLASTAN, NAPROXEN. Patient was hospitalized. Patient died.

Cancidas Side Effects Report #5492923-X
Cancidas side effect was reported by a Consumer or non-health professional from SPAIN on Sept 14, 2007. Female patient, 50 years of age, was diagnosed with lower respiratory tract infection fungal, aplastic anaemia and was treated with Cancidas. After drug was administered, patient experienced the following side effects: bilirubin conjugated increased, jaundice , respiratory failure. Cancidas dosage: 70 MG/DAILY IV. During the same period patient was treated with CYCLOSPORINE, SULFAMETHOXAZOLE TRIMETHOPRIM, MYOLASTAN, NAPROXEN. Patient was hospitalized. Patient died.

Cancidas Side Effects Report #5768244-4
Cancidas side effect was reported by a Consumer or non-health professional from SPAIN on June 03, 2008. Female patient, 50 years of age, was diagnosed with lower respiratory tract infection fungal, aplastic anaemia and was treated with Cancidas. After drug was administered, patient experienced the following side effects: jaundice , respiratory failure. Cancidas dosage: 70 MG/DAILY IV. During the same period patient was treated with CYCLOSPORINE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, TETRAZEPAM, NAPROXEN. Patient was hospitalized. Patient died.

Cancidas Side Effects Report #4627448-4
Cancidas side effect was reported by a Physician from on Mar 10, 2005. Female patient, 45 years of age, was diagnosed with fungal infection , leukaemia and was treated with Cancidas. After drug was administered, patient experienced the following side effects: hepatic enzyme increased, hepatic necrosis, jaundice , pneumocystis jiroveci infection. Cancidas dosage: unknown. During the same period patient was treated with CYCLOSPORINE, CYCLOPHOSPHAMIDE, DOXORUBICIN, ESCITALOPRAM OXALATE, MEDROXYPROGESTERONE ACETATE, CEFEPIME, VANCOMYCIN. Patient died.


Cancidas Side Effects Report #4631312-4
Cancidas side effect was reported by a Physician from on Mar 10, 2005. Female patient, 45 years of age, was diagnosed with fungal infection , chronic myeloid leukaemia and was treated with Cancidas. After drug was administered, patient experienced the following side effects: hepatic enzyme increased, hepatic necrosis, jaundice , pneumocystis jiroveci infection. Cancidas dosage: unknown. During the same period patient was treated with CYCLOSPORINE, CYCLOPHOSPHAMIDE, ESCITALOPRAM OXALATE, MEDROXYPROGESTERONE ACETATE, CEFEPIME, VANCOMYCIN, ACYCLOVIR. Patient died.

Cancidas Side Effects Report #4635142-9
Cancidas side effect was reported by a Physician from on Mar 10, 2005. Female patient, 45 years of age, was diagnosed with fungal infection , chronic myeloid leukaemia and was treated with Cancidas. After drug was administered, patient experienced the following side effects: hepatic enzyme increased, hepatic necrosis, jaundice , pneumocystis jiroveci infection. Cancidas dosage: unknown. During the same period patient was treated with CYCLOSPORINE, CYCLOPHOSPHAMIDE, ESCITALOPRAM OXALATE, MEDROXYPROGESTERONE ACETATE, CEFEPIME, VANCOMYCIN, ACYCLOVIR. Patient died.

Cancidas Side Effects Report #4661643-3
Cancidas side effect was reported by a Physician from on Mar 10, 2005. Female patient, 45 years of age, was diagnosed with fungal infection , chronic myeloid leukaemia and was treated with Cancidas. After drug was administered, patient experienced the following side effects: hepatic enzyme increased, hepatic necrosis, jaundice , pneumocystis jiroveci infection. Cancidas dosage: unknown. During the same period patient was treated with CYCLOSPORINE, CYCLOPHOSPHAMIDE, ESCITALOPRAM OXALATE, MEDROXYPROGESTERONE ACETATE, CEFEPIME, VANCOMYCIN, ACYCLOVIR. Patient died.

Cancidas Side Effects Report #5207922-2
Cancidas side effect was reported by a Consumer or non-health professional from TAIWAN, PROVINCE OF CHINA on Dec 29, 2006. Female patient, 79 years of age, was diagnosed with candidiasis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, endocarditis enterococcal, hyperbilirubinaemia, jaundice , peritonitis. Cancidas dosage: unknown. During the same period patient was treated with METRONIDAZOLE, PIPERACILLIN. Patient was hospitalized. Patient recovered.

Cancidas Side Effects Report #5744874-0
Cancidas side effect was reported by a Consumer or non-health professional from TAIWAN, PROVINCE OF CHINA on May 01, 2008. Female patient, 79 years of age, was diagnosed with candidiasis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood glucose decreased, enterococcal bacteraemia, hepatic function abnormal, hyperbilirubinaemia, jaundice , peritonitis. Cancidas dosage: 150 MG/DAILY IV. During the same period patient was treated with ATROVENT, AZACTAM, BRICANYL, CIPROFLOXACIN, DIFLUCAN, FENTANYL ORALET, FORTUM, FAMOTIDINE. Patient was hospitalized. Patient recovered.